| Date | Time | Source | Announcement |
|---|---|---|---|
| 22 Nov 2006 | 10:00 AM | Holding(s) in Company | |
| 20 Nov 2006 | 03:12 PM | Holding(s) in Company | |
| 16 Nov 2006 | 07:00 AM | Research Update | |
| 14 Nov 2006 | 04:09 PM | Holding(s) in Company | |
| 08 Nov 2006 | 09:08 AM | Director/PDMR Shareholding | |
| 06 Nov 2006 | 12:49 PM | Holding(s) in Company | |
| 02 Nov 2006 | 01:59 PM | Holding(s) in Company | |
| 31 Oct 2006 | 09:47 AM | Holding(s) in Company | |
| 31 Oct 2006 | 09:38 AM | Holding(s) in Company | |
| 31 Oct 2006 | 07:00 AM | Research Update | |
| 26 Oct 2006 | 07:00 AM | Director/PDMR Shareholding | |
| 25 Oct 2006 | 07:00 AM | Issue of Equity | |
| 12 Oct 2006 | 07:00 AM | Re Agreement | |
| 21 Sep 2006 | 09:46 AM | Director/PDMR Shareholding | |
| 18 Sep 2006 | 10:24 AM | Holding(s) in Company | |
| 13 Sep 2006 | 08:54 AM | Holding(s) in Company | |
| 12 Sep 2006 | 12:11 PM | Holding(s) in Company | |
| 12 Sep 2006 | 07:00 AM | Interim Results | |
| 04 Sep 2006 | 07:00 AM | Notice of Results | |
| 30 Aug 2006 | 02:39 PM | Holding(s) in Company | |
| 15 Aug 2006 | 07:00 AM | Notice of Interim Results | |
| 09 Aug 2006 | 02:20 PM | Holding(s) in Company | |
| 20 Jun 2006 | 07:00 AM | Ph II Cataract Trial Starts | |
| 13 Jun 2006 | 07:00 AM | Ph IIb Hay Fever Trial Starts | |
| 24 May 2006 | 07:00 AM | Case Western Collaboration | |
| 23 May 2006 | 07:00 AM | Board Appointment | |
| 16 May 2006 | 07:00 AM | US Appointment | |
| 15 May 2006 | 07:01 AM | Conference Webcast | |
| 10 May 2006 | 04:26 PM | Holding(s) in Company | |
| 26 Apr 2006 | 04:50 PM | Result of AGM | |
| 04 Apr 2006 | 07:00 AM | Merial Option Agreement | |
| 13 Mar 2006 | 07:01 AM | Boston Conference Webcast | |
| 01 Mar 2006 | 09:27 AM | Director/PDMR Shareholding | |
| 28 Feb 2006 | 07:00 AM | Preliminary Results | |
| 27 Feb 2006 | 10:06 AM | Positive Preclinical Data | |
| 10 Feb 2006 | 11:49 AM | Holding(s) in Company | |
| 23 Jan 2006 | 07:00 AM | New study data | |
| 12 Dec 2005 | 01:32 PM | Holding(s) in Company | |
| 15 Nov 2005 | 05:28 PM | Holding(s) in Company | |
| 15 Nov 2005 | 11:34 AM | Holding(s) in Company | |
| 15 Nov 2005 | 11:31 AM | Holding(s) in Company | |
| 15 Nov 2005 | 11:23 AM | Holding(s) in Company | |
| 14 Nov 2005 | 07:00 AM | Change of Adviser | |
| 09 Nov 2005 | 12:40 PM | Result of EGM | |
| 28 Oct 2005 | 03:09 PM | Director/PDMR Shareholding | |
| 25 Oct 2005 | 07:00 AM | Business Development Appt. | |
| 14 Oct 2005 | 11:23 AM | Fundraising | |
| 03 Oct 2005 | 07:00 AM | Research Appointment | |
| 28 Sep 2005 | 07:00 AM | Interim Results | |
| 27 Sep 2005 | 01:00 PM | Notice of Webcast |
Nanoco Group is a nanomaterial production and licensing company that specializes in cadmium-free quantum dots and other semiconductor nanomaterials. Nanoco's products include cadmium-free quantum dots and HEATWAVE quantum dots. CFQD quantum dots are used for OLED and µLED color conversion, QD-EL, and security. HEATWAVE quantum dots are used in cameras and image sensors.
Nanoco operates in the United Kingdom, Europe, Asia, and the United States.
Nanoco's headquarters are in Runcorn, UK, where the company's R&D and manufacturing activities are also based.
Nanoco share price listed at 127p in 2004 under the ticker NANO.